DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
This Quarter Return
+8.55%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
+$262M
(-0.11%)
Cap. Flow
-$12.9M
Cap. Flow
% of AUM
-4.91%
Top 10 Holdings %
Top 10 Hldgs %
74.48%
Holding
143
New
12
Increased
13
Reduced
9
Closed
30
Top Buys
| 1 |
Panagram BBB-B CLO ETF
CLOZ
|
$15.8M |
| 2 |
Invesco AAA CLO Floating Rate Note ETF
ICLO
|
$5.87M |
| 3 |
Janus Henderson AAA CLO ETF
JAAA
|
$3.13M |
| 4 |
Sanofi
SNY
|
$2.34M |
| 5 |
Catalyst Pharmaceutical
CPRX
|
$2.11M |
Top Sells
| 1 |
MDWT
Midwest Holding Inc. Common Stock
MDWT
|
$10.2M |
| 2 |
MITAW
Coliseum Acquisition Corp. Warrant
MITAW
|
$5.69M |
| 3 |
Calumet Specialty Products
CLMT
|
$4.49M |
| 4 |
FBRT
Franklin BSP Realty Trust
FBRT
|
$4.34M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$3.82M |
Sector Composition
| 1 | Materials | 30.32% |
| 2 | Healthcare | 27.82% |
| 3 | Financials | 10.27% |
| 4 | Industrials | 8.49% |
| 5 | Communication Services | 6.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Calumet Specialty Products
CLMT
$1.41B
| $77.3M | 29.54% | 4,325,000 -251,000 | -5% | -$4.49M |
|
2
Apollo Global Management
APO
$77.9B
| $21M | 8.01% | 225,000 | – | – |
|
3
FTAI Aviation
FTAI
$15.8B
| $19.7M | 7.54% | 425,000 | – | – |
|
|
4
Panagram BBB-B CLO ETF
CLOZ
$846M
| $19M | 7.26% | 719,368 +598,336 | +494% | +$15.8M |
|
5
Alphabet (Google) Class C
GOOG
$2.58T
| $15.8M | 6.04% | 112,220 | – | – |
|
6
DocGo
DCGO
$153M
| $10.8M | 4.11% | 1,925,000 | – | – |
|
7
Ardelyx
ARDX
$1.53B
| $8.56M | 3.27% | 1,380,000 -120,000 | -8% | -$744K |
|
8
Ligand Pharmaceuticals
LGND
$3.15B
| $8.21M | 3.14% | 115,000 | – | – |
|
|
9
Invesco AAA CLO Floating Rate Note ETF
ICLO
$344M
| $7.85M | 3% | 307,019 +229,642 | +297% | +$5.87M |
|
10
OmniAb
OABI
$230M
| $6.7M | 2.56% | 1,086,505 | – | – |
|
11
Viking Therapeutics
VKTX
$3.04B
| $5.04M | 1.93% | 270,822 +85,267 | +46% | +$1.59M |
|
|
12
Janus Henderson AAA CLO ETF
JAAA
$24.9B
| $4.71M | 1.8% | 93,647 +62,215 | +198% | +$3.13M |
|
13
JPMorgan Chase
JPM
$829B
| $3.57M | 1.36% | 20,985 | – | – |
|
|
AVDL
14
Avadel Pharmaceuticals
AVDL
$1.43B
| $3.56M | 1.36% | 251,850 +30,000 | +14% | +$424K |
|
15
Madrigal Pharmaceuticals
MDGL
$9.76B
| $3.42M | 1.31% | 14,800 -200 | -1% | -$46.3K |
|
16
Pfizer
PFE
$141B
| $2.81M | 1.07% | 97,537 | – | – |
|
17
CSX Corp
CSX
$60.6B
| $2.43M | 0.93% | 70,000 | – | – |
|
18
GSK
GSK
$79.9B
| $2.41M | 0.92% | 65,000 | – | – |
|
|
INZY
19
DELISTED
Inozyme Pharma
INZY
| $2.41M | 0.92% | 564,549 +110,541 | +24% | +$471K |
|
20
Panagram AAA CLO ETF
CLOX
$220M
| $2.35M | 0.9% | 92,956 +77,316 | +494% | +$1.96M |
|
|
21
Sanofi
SNY
$121B
| $2.34M | 0.89% | +47,000 | New | +$2.34M |
|
|
22
Catalyst Pharmaceutical
CPRX
$2.52B
| $2.11M | 0.81% | +125,450 | New | +$2.11M |
|
23
Travere Therapeutics
TVTX
$1.56B
| $1.99M | 0.76% | 221,005 +120,688 | +120% | +$1.09M |
|
24
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $1.75M | 0.67% | 526,312 -103,688 | -16% | -$345K |
|
25
Cenovus Energy
CVE
$29.9B
| $1.58M | 0.6% | 95,000 | – | – |
|